» Articles » PMID: 35852052

Postural Orthostatic Tachycardia Syndrome and Migraine: A narrative Review

Overview
Journal Headache
Publisher Wiley
Specialties Neurology
Psychiatry
Date 2022 Jul 19
PMID 35852052
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: In this narrative review, we summarize experimental and clinical evidence demonstrating mechanistic connections between POTS and migraine.

Background: Migraine is the most common comorbidity in patients with POTS, a heterogenous disorder of the autonomic nervous system characterized by orthostatic intolerance and positional tachycardia. POTS is a debilitating illness with few effective treatments. We aim for this narrative review to increase awareness of the mechanistic connections between POTS and migraine providing foundational information that optimizes clinical care and advances the development of pathophysiologic-based treatments.

Methods: We used the PubMed and Medline databases in November 2021 to perform a literature review and searched for the following keywords: "postural orthostatic tachycardia syndrome," "POTS," "autonomic nervous system," AND "migraine," "headache."

Results: The high prevalence of migraine in patients with POTS may be explained by common pathologic mechanisms. There is evidence that dysregulation of the sympathetic nervous system, alterations in central and peripheral hemodynamics, and central sensitization increase vulnerability to both POTS and migraine. Non-pharmacologic and pharmacologic treatments that target these shared mechanisms may provide significant benefit for the patient with POTS and migraine.

Conclusions: Identification of common affected pathways may provide important insight that advances our understanding and treatment of both migraine and POTS.

Citing Articles

Narrative Review of Postural Orthostatic Tachycardia Syndrome: Associated Conditions and Management Strategies.

Steinberg R, Dicken W, Cutchins A US Cardiol. 2024; 17:e13.

PMID: 39559520 PMC: 11571393. DOI: 10.15420/usc.2022.35.


Factors associated with initiation of pharmacological therapy and treatment changes in postural orthostatic tachycardia syndrome.

Tidd S, Zhang R, Cantrell C, Nowacki A, Singh T, Wilson R Front Neurol. 2024; 15:1411960.

PMID: 38966085 PMC: 11222644. DOI: 10.3389/fneur.2024.1411960.


Diagnosis and Treatment of Spontaneous Intracranial Hypotension: Role of Epidural Blood Patching.

Callen A, Friedman D, Parikh S, Rau J, Schievink W, Cutsforth-Gregory J Neurol Clin Pract. 2024; 14(3):e200290.

PMID: 38699599 PMC: 11065326. DOI: 10.1212/CPJ.0000000000200290.


Plasma metabolomic profile in orthostatic intolerance children with high levels of plasma homocysteine.

Li Y, Bai B, Wang H, Wu H, Deng Y, Shen C Ital J Pediatr. 2024; 50(1):52.

PMID: 38486257 PMC: 10941598. DOI: 10.1186/s13052-024-01601-4.


Possible Role of Fibrinaloid Microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID.

Kell D, Khan M, Kane B, Lip G, Pretorius E J Pers Med. 2024; 14(2).

PMID: 38392604 PMC: 10890060. DOI: 10.3390/jpm14020170.